Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Finerty

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Cancer Research|June 5, 2001
Melanoma biology and progressionM Herlyn, S Ferrone, Z Ronai, et al.
Biochemistry|January 12, 2005
NMR dynamics-derived insights into the binding properties of a peptide interacting with an SH2 domainPatrick J Finerty, Anthony K Mittermaier, Ranjith Muhandiram, et al.
Journal of Molecular Biology|December 13, 2006
The crystal structures of human calpains 1 and 9 imply diverse mechanisms of action and auto-inhibitionTara L Davis, John R Walker, Patrick J Finerty, et al.
Growth Factors (Chur, Switzerland)|January 11, 1991
Expression of recombinant TGF-beta 2(442) precursor and detection in BSC-40 cellsL Madisen, M N Lioubin, P J Finerty, et al.
Biochemical and Biophysical Research Communications|September 16, 2006
Structure of human protein kinase C eta (PKCeta) C2 domain and identification of phosphorylation sitesDene R Littler, John R Walker, Yi-Min She, et al.
The Journal of Biological Chemistry|October 13, 2006
Amino-terminal dimerization, NRDP1-rhodanese interaction, and inhibited catalytic domain conformation of the ubiquitin-specific protease 8 (USP8)George V Avvakumov, John R Walker, Sheng Xue, et al.
The Journal of Biological Chemistry|March 20, 2010
Crystal structures of human choline kinase isoforms in complex with hemicholinium-3: single amino acid near the active site influences inhibitor sensitivityBum Soo Hong, Abdellah Allali-Hassani, Wolfram Tempel, et al.
Bioorganic & Medicinal Chemistry Letters|June 26, 2009
Discovery and structural analysis of Eph receptor tyrosine kinase inhibitorsYongmun Choi, Farisa Syeda, John R Walker, et al.
Acta Crystallographica. Section F, Structural Biology and Crystallization Communications|February 4, 2010
A conserved mechanism of autoinhibition for the AMPK kinase domain: ATP-binding site and catalytic loop refolding as a means of regulationDene R Littler, John R Walker, Tara Davis, et al.
Plos Biology|August 3, 2010
Structural and biochemical characterization of the human cyclophilin family of peptidyl-prolyl isomerasesTara L Davis, John R Walker, Valérie Campagna-Slater, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Cancer Research|June 5, 2001
Melanoma biology and progressionM Herlyn, S Ferrone, Z Ronai, et al.
Biochemistry|January 12, 2005
NMR dynamics-derived insights into the binding properties of a peptide interacting with an SH2 domainPatrick J Finerty, Anthony K Mittermaier, Ranjith Muhandiram, et al.
Journal of Molecular Biology|December 13, 2006
The crystal structures of human calpains 1 and 9 imply diverse mechanisms of action and auto-inhibitionTara L Davis, John R Walker, Patrick J Finerty, et al.
Growth Factors (Chur, Switzerland)|January 11, 1991
Expression of recombinant TGF-beta 2(442) precursor and detection in BSC-40 cellsL Madisen, M N Lioubin, P J Finerty, et al.
Biochemical and Biophysical Research Communications|September 16, 2006
Structure of human protein kinase C eta (PKCeta) C2 domain and identification of phosphorylation sitesDene R Littler, John R Walker, Yi-Min She, et al.
The Journal of Biological Chemistry|October 13, 2006
Amino-terminal dimerization, NRDP1-rhodanese interaction, and inhibited catalytic domain conformation of the ubiquitin-specific protease 8 (USP8)George V Avvakumov, John R Walker, Sheng Xue, et al.
The Journal of Biological Chemistry|March 20, 2010
Crystal structures of human choline kinase isoforms in complex with hemicholinium-3: single amino acid near the active site influences inhibitor sensitivityBum Soo Hong, Abdellah Allali-Hassani, Wolfram Tempel, et al.
Bioorganic & Medicinal Chemistry Letters|June 26, 2009
Discovery and structural analysis of Eph receptor tyrosine kinase inhibitorsYongmun Choi, Farisa Syeda, John R Walker, et al.
Acta Crystallographica. Section F, Structural Biology and Crystallization Communications|February 4, 2010
A conserved mechanism of autoinhibition for the AMPK kinase domain: ATP-binding site and catalytic loop refolding as a means of regulationDene R Littler, John R Walker, Tara Davis, et al.
Plos Biology|August 3, 2010
Structural and biochemical characterization of the human cyclophilin family of peptidyl-prolyl isomerasesTara L Davis, John R Walker, Valérie Campagna-Slater, et al.
Pageof 3